Replies to post #280 on UniCycive Therapeutics Inc (UNCY)

[Mr.Mister]

Now I am curious why this is taking so long. Wasn't tolerability a secondary endpoint during the phase 1 trial?

[rosemountbomber]

Well looks like that didn’t happen. But don’t stop with the predictions. Huge dilution with RZLT but we shall see. CEO fooled me if he was lying about interest in their DME drug. I thought it was a talk that gave confidence in the company but what the heck do I know.